---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-348468"
form_type: "8-K"
ticker: "CRIS"
cik: "0001108205"
company_name: "CURIS INC"
filed_at: "2021-12-06T23:59:59+00:00"
generated_at: "2026-06-28T03:24:07.246750+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Curis appoints Dr. John A. Hohneker to Board of Directors

## Summary
- Dr. Hohneker elected as Class II director on Dec 2, 2021, term until 2022 annual meeting.
- Receives standard non-employee director compensation: one-time option for 25,000 shares vesting over 4 years.
- Brings 30 years of drug development experience; former President/CEO of Anokion and President of R&D at FORMA Therapeutics.
- Expected to help advance CA-4948 (IRAK4 inhibitor) toward potential approval and commercialization.

## SEC filing metadata
- accession: 0001193125-21-348468
- form_type: 8-K
- ticker: CRIS
- cik: 0001108205
- company_name: CURIS INC
- filed_at: 2021-12-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1108205/000119312521348468/0001193125-21-348468-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1108205/000119312521348468/d270245d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-348468
- JSON: https://secwatch.observer/filing/0001193125-21-348468.json
- Plain text: https://secwatch.observer/filing/0001193125-21-348468.txt

## Key facts
- Executive change
  John A. Hohneker, M.D. was elected as Director at CURIS INC.
  - Action: elected
  - Role: Director
  source text: On December 2, 2021, the Board of Directors (“Board”) of Curis, Inc. (the “Company”) elected John A. Hohneker, M.D., to serve as a class II director until the 2022 Annual Meeting of Stockholders and thereafter until his successor is duly elected and qualified.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1108205/000119312521348468/0001193125-21-348468-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.